Kyle RA - Search Results

1

Lymphoplasmacytic Lymphoma With a Non-IgM Paraprotein Shows Clinical and Pathologic Heterogeneity and May Harbor MYD88 L265P Mutations.

King RL, Gonsalves WI, Ansell SM, Greipp PT, Frederick LA, Viswanatha DS, He R, Kyle RA, Gertz MA, Kapoor P, Morice WG, Howard MT. King RL, et al. Among authors: kyle ra. Am J Clin Pathol. 2016 Jun;145(6):843-51. doi: 10.1093/ajcp/aqw072. Epub 2016 Jun 21. Am J Clin Pathol. 2016. PMID: 27329639

2

Immunohistochemical characterization of amyloid proteins in sural nerves and clinical associations in amyloid neuropathy.

Li K, Kyle RA, Dyck PJ. Li K, et al. Among authors: kyle ra. Am J Pathol. 1992 Jul;141(1):217-26. Am J Pathol. 1992. PMID: 1321563 Free PMC article.

3

Amyloid localized to tenosynovium at carpal tunnel release. Immunohistochemical identification of amyloid type.

Kyle RA, Gertz MA, Linke RP. Kyle RA, et al. Am J Clin Pathol. 1992 Feb;97(2):250-3. doi: 10.1093/ajcp/97.2.250. Am J Clin Pathol. 1992. PMID: 1372147

4

Familial amyloidosis: a study of 52 North American-born patients examined during a 30-year period.

Gertz MA, Kyle RA, Thibodeau SN. Gertz MA, et al. Among authors: kyle ra. Mayo Clin Proc. 1992 May;67(5):428-40. doi: 10.1016/s0025-6196(12)60388-7. Mayo Clin Proc. 1992. PMID: 1405768

5

Dialysis support of patients with primary systemic amyloidosis. A study of 211 patients.

Gertz MA, Kyle RA, O'Fallon WM. Gertz MA, et al. Among authors: kyle ra. Arch Intern Med. 1992 Nov;152(11):2245-50. Arch Intern Med. 1992. PMID: 1444684

6

Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989.

Kyle RA, Linos A, Beard CM, Linke RP, Gertz MA, O'Fallon WM, Kurland LT. Kyle RA, et al. Blood. 1992 Apr 1;79(7):1817-22. Blood. 1992. PMID: 1558973 Free article.

7

Computed tomography for diagnosis of hepatic rupture in primary systemic amyloidosis.

Gastineau DA, Gertz MA, Rosen CB, Kyle RA. Gastineau DA, et al. Among authors: kyle ra. Am J Hematol. 1991 Jul;37(3):194-6. doi: 10.1002/ajh.2830370312. Am J Hematol. 1991. PMID: 1858771

8

Abnormal cytogenetics predict poor survival after high-dose therapy and autologous blood cell transplantation in multiple myeloma.

Rajkumar S, Fonseca R, Lacy M, Witzig T, Lust J, Greipp P, Therneau T, Kyle R, Litzow M, Gertz M. Rajkumar S, et al. Bone Marrow Transplant. 1999 Sep;24(5):497-503. doi: 10.1038/sj.bmt.1701943. Bone Marrow Transplant. 1999. PMID: 10482933

9

Deletions of 17p13.1 and 13q14 are uncommon in Waldenström macroglobulinemia clonal cells and mostly seen at the time of disease progression.

Schop RF, Jalal SM, Van Wier SA, Ahmann GJ, Bailey RJ, Kyle RA, Greipp PR, Rajkumar SV, Gertz MA, Lust JA, Lacy MQ, Dispenzieri A, Witzig TE, Fonseca R. Schop RF, et al. Among authors: kyle ra. Cancer Genet Cytogenet. 2002 Jan 1;132(1):55-60. doi: 10.1016/s0165-4608(01)00526-x. Cancer Genet Cytogenet. 2002. PMID: 11801310

10

A multicenter phase II trial of 4'-iodo-4'deoxydoxorubicin (IDOX) in primary amyloidosis (AL).

Gertz MA, Lacy MQ, Dispenzieri A, Cheson BD, Barlogie B, Kyle RA, Palladini G, Geyer SM, Merlini G. Gertz MA, et al. Among authors: kyle ra. Amyloid. 2002 Mar;9(1):24-30. doi: 10.3109/13506120209072441. Amyloid. 2002. PMID: 12000194 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,538 results

Search Page

Filters